Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
N/A
General Information
Revision date
2020-01-17
Product name
GSK3368715B TABLETS
Product Synonyms
ETHER CYCLOHEXYL DERIVATIVE * GSK3368715 TABLETS, FORMULATED PRODUCT
1.2.1 Relevant identified uses
Investigational Medicinal Product
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H361, H372
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 4 H302 - Harmful if swallowed. Reproductive toxicity Category 2 H361 - Suspected of damaging fertility or the unborn child. Specific target organ toxicity - repeated Category 1 H372 - Causes damage to organs exposure through prolonged or repeated exposure. Hazard summary Assume that this product is capable of sustaining combustion. Caution - Potent pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
CROSCARMELLOSE SODIUM, GSK3368715B, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, Titanium dioxide
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H361 Suspected of damaging fertility or the unborn child. H372 Causes damage to organs through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTRE/doctor/ if you feel unwell. P330 Rinse mouth. P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
37,7 % of the mixture consists of component(s) of unknown acute oral toxicity. 73,25 % of the mixture consists of component(s) of unknown acute dermal toxicity. 73,25 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 73,25 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Assume that this product is capable of sustaining combustion. Caution - Potent pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
